Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature. 2020

Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.

BACKGROUND The prevalence of primary aldosteronism concurrent with subclinical Cushing's syndrome was higher than previously thought. Through analyzing a rare clinical case, we summarized the diagnosis and management of primary aldosteronism with subclinical Cushing's syndrome. METHODS A 54-year-old Chinese man of Han nationality was diagnosed as having primary aldosteronism with subclinical Cushing's syndrome. An abdominal computed tomography scan revealed a mass in his left adrenal gland and a mass in his right adrenal gland. After finishing sequential adrenal venous sampling without adrenocorticotropic hormone, the result reminded us that the left and right nodules were responsible for hypercortisolism and aldosterone hypersecretion, respectively. Right and left adrenalectomy were performed successively. The pathological diagnosis was adrenocortical adenoma for both. Histological findings revealed that the right one had positive immunostaining for CYP11B2 and the left one had positive immunostaining for CYP11B1. The immunohistochemistry result helped us to confirm the diagnosis. Somatic KCNJ5 mutation (Leu168Arg) was found in the right tumor; there was no KCNJ5 mutation in the left adrenal tumor. CONCLUSIONS We suggest that patients with primary aldosteronism should have a low-dose overnight dexamethasone suppression test to screen for hypercortisolism. It can help avoid misdiagnoses and contribute to proper understanding of the adrenal vein sampling result. Making sure of the nidus of aldosterone and cortisol secretion is crucial for the therapy of patients with primary aldosteronism and subclinical Cushing's syndrome.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000315 Adrenalectomy Excision of one or both adrenal glands. (From Dorland, 28th ed) Adrenalectomies

Related Publications

Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
November 2013, Hinyokika kiyo. Acta urologica Japonica,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
March 2016, The Tokai journal of experimental and clinical medicine,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
May 2015, Hinyokika kiyo. Acta urologica Japonica,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
February 2021, World journal of clinical cases,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
January 2011, Endocrine journal,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
July 2020, BMC pregnancy and childbirth,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
January 2023, Open life sciences,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
September 2020, Zhonghua yi xue za zhi,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
January 2020, BMC endocrine disorders,
Yingxiao Zhang, and Jianyu Tan, and Qin Yang, and Zhipeng Du, and Shumin Yang, and Wenwen He, and Ying Song, and Jinbo Hu, and Yi Yang, and Qifu Li, and Yao Zhang, and Yunfeng He, and Qingfeng Cheng, and
June 2018, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!